Standout Papers
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study (2003)
- KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer (2006)
- KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab (2008)
- Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer (2009)
Immediate Impact
1 by Nobel laureates 3 from Science/Nature 161 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Works of Bruno Landi being referenced
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
2006 Standout
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bruno Landi | 5828 | 1630 | 2815 | 1874 | 68 | 8.1k | |
| Joan Maurel | 6768 | 2054 | 3349 | 1583 | 214 | 8.6k | |
| Harry Bleiberg | 7126 | 2433 | 4086 | 1398 | 160 | 10.0k | |
| Piercarlo Saletti | 4167 | 919 | 2040 | 1565 | 74 | 5.4k | |
| Cecilia M. Fenoglio‐Preiser | 4489 | 1971 | 2337 | 2127 | 112 | 7.5k | |
| Allen Lee Cohn | 4629 | 837 | 2314 | 992 | 158 | 6.7k | |
| Astrid Lièvre | 4321 | 1275 | 2182 | 1701 | 171 | 6.1k | |
| Vladimir Moiseyenko | 5471 | 1731 | 4049 | 682 | 127 | 7.9k | |
| Arnaud Roth | 3334 | 1251 | 1798 | 1425 | 115 | 5.0k | |
| Jae Kyung Roh | 4123 | 1144 | 1774 | 1303 | 151 | 5.7k | |
| Christopher R. Garrett | 2754 | 938 | 2358 | 758 | 49 | 5.2k |
All Works
Loading papers...